Immunosuppressive therapy in liver transplantation
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 39 (5) , 664-678
- https://doi.org/10.1016/s0168-8278(03)00428-8
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver diseaseLiver Transplantation, 2003
- Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patientsTransplantation, 2002
- Long-term Safety, Tolerability and Efficacy of Daclizumab (Zenapax®) in a Two-dose Regimen in Liver Transplant RecipientsAmerican Journal of Transplantation, 2002
- Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipientsLiver Transplantation, 2002
- CyclosporinDrugs, 2001
- BasiliximabDrugs, 1999
- Is acute rejection deleterious to long-term allograft function?Journal of Hepatology, 1998
- Cyclosporin MicroemulsionBioDrugs, 1997
- Mycophenolate MofetilDrugs, 1996
- Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationHepatology, 1995